Eastland Medical Systems

The Company’s two key projects are ArTiMist™, a malaria treatment developed specifically for children with severe malaria and NiCoSorb™, a nicotine replacement therapy. 

ArTiMist has the potential to save countless young lives throughout third world and underprivileged regions.

NiCoSorb, an anti-smoking therapy, is another life-saving treatment which will assist smokers in their efforts to quit the habit.

Growth Strategy
Eastland is committed to developing its pharmaceutical business model by expanding its product portfolio with products that demonstrate major cost, functional and effectual advantages over competitors, thereby securing on-going consumer demand.